<?xml version='1.0' encoding='utf-8'?>
<document id="19801894"><sentence text="Inhibitory effects of ketoconazole, cimetidine and erythromycin on hepatic CYP3A activities in cats."><entity charOffset="22-34" id="DDI-PubMed.19801894.s1.e0" text="ketoconazole" /><entity charOffset="36-46" id="DDI-PubMed.19801894.s1.e1" text="cimetidine" /><entity charOffset="51-63" id="DDI-PubMed.19801894.s1.e2" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.19801894.s1.e0" e2="DDI-PubMed.19801894.s1.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s1.e0" e2="DDI-PubMed.19801894.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s1.e0" e2="DDI-PubMed.19801894.s1.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s1.e1" e2="DDI-PubMed.19801894.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s1.e1" e2="DDI-PubMed.19801894.s1.e2" /></sentence><sentence text="Inhibitory effects of ketoconazole (KTZ), cimetidine (CIM), and erythromycin (ERY) were examined on CYP3A activities"><entity charOffset="22-34" id="DDI-PubMed.19801894.s2.e0" text="ketoconazole" /><entity charOffset="36-39" id="DDI-PubMed.19801894.s2.e1" text="KTZ" /><entity charOffset="42-52" id="DDI-PubMed.19801894.s2.e2" text="cimetidine" /><entity charOffset="54-57" id="DDI-PubMed.19801894.s2.e3" text="CIM" /><entity charOffset="64-76" id="DDI-PubMed.19801894.s2.e4" text="erythromycin" /><entity charOffset="78-81" id="DDI-PubMed.19801894.s2.e5" text="ERY" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e0" e2="DDI-PubMed.19801894.s2.e5" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e1" e2="DDI-PubMed.19801894.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e1" e2="DDI-PubMed.19801894.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e1" e2="DDI-PubMed.19801894.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e1" e2="DDI-PubMed.19801894.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e1" e2="DDI-PubMed.19801894.s2.e5" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e2" e2="DDI-PubMed.19801894.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e2" e2="DDI-PubMed.19801894.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e2" e2="DDI-PubMed.19801894.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e2" e2="DDI-PubMed.19801894.s2.e5" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e3" e2="DDI-PubMed.19801894.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e3" e2="DDI-PubMed.19801894.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e3" e2="DDI-PubMed.19801894.s2.e5" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e4" e2="DDI-PubMed.19801894.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19801894.s2.e4" e2="DDI-PubMed.19801894.s2.e5" /></sentence><sentence text=" Midazolam 1'- and 4-hydroxylation (MDZ1'H and MDZ4H) were used to determine CYP3A activities in hepatic microsomes obtained from cats (n=4)" /><sentence text=" The results showed that, all the examined drugs inhibited the reactions in a noncompetitive manner" /><sentence text=" The inhibitory constants (Ki) of KTZ were 2"><entity charOffset="34-36" id="DDI-PubMed.19801894.s5.e0" text="KTZ" /></sentence><sentence text="80 +/- 0" /><sentence text="70 and 115 +/- 28 microM for MDZ1'H and MDZ4H, respectively" /><sentence text=" Those of CIM were 3"><entity charOffset="10-12" id="DDI-PubMed.19801894.s8.e0" text="CIM" /></sentence><sentence text="13 and 3" /><sentence text="27 mM and of ERY were 3"><entity charOffset="13-15" id="DDI-PubMed.19801894.s10.e0" text="ERY" /></sentence><sentence text="14 and 6" /><sentence text="41 mM for MDZ1'H and MDZ4H, respectively"><entity charOffset="21-26" id="DDI-PubMed.19801894.s12.e0" text="MDZ4H" /></sentence><sentence text=" Mechanism-based inhibition was also examined in this study" /><sentence text=" KTZ significantly reduced MDZ reactions in a time-dependent manner; while CIM and ERY did not"><entity charOffset="1-5" id="DDI-PubMed.19801894.s14.e0" text="KTZ" /><entity charOffset="75-79" id="DDI-PubMed.19801894.s14.e1" text="CIM" /><entity charOffset="83-87" id="DDI-PubMed.19801894.s14.e2" text="ERY" /><pair ddi="false" e1="DDI-PubMed.19801894.s14.e0" e2="DDI-PubMed.19801894.s14.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s14.e0" e2="DDI-PubMed.19801894.s14.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s14.e0" e2="DDI-PubMed.19801894.s14.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s14.e1" e2="DDI-PubMed.19801894.s14.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s14.e1" e2="DDI-PubMed.19801894.s14.e2" /></sentence><sentence text=" Also, the effects of KTZ and CIM on the pharmacokinetics of quinidine (QUN) were studied"><entity charOffset="61-70" id="DDI-PubMed.19801894.s15.e0" text="quinidine" /><entity charOffset="72-75" id="DDI-PubMed.19801894.s15.e1" text="QUN" /><entity charOffset="22-24" id="DDI-PubMed.19801894.s15.e2" text="KTZ" /><entity charOffset="30-32" id="DDI-PubMed.19801894.s15.e3" text="CIM" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e2" e2="DDI-PubMed.19801894.s15.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e2" e2="DDI-PubMed.19801894.s15.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e2" e2="DDI-PubMed.19801894.s15.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e2" e2="DDI-PubMed.19801894.s15.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e3" e2="DDI-PubMed.19801894.s15.e3" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e3" e2="DDI-PubMed.19801894.s15.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e3" e2="DDI-PubMed.19801894.s15.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e0" e2="DDI-PubMed.19801894.s15.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s15.e0" e2="DDI-PubMed.19801894.s15.e1" /></sentence><sentence text=" KTZ or CIM (10 mg/kg/day, for one week) was given orally to cats (n=5)"><entity charOffset="1-3" id="DDI-PubMed.19801894.s16.e0" text="KTZ" /><entity charOffset="8-10" id="DDI-PubMed.19801894.s16.e1" text="CIM" /><pair ddi="false" e1="DDI-PubMed.19801894.s16.e0" e2="DDI-PubMed.19801894.s16.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s16.e0" e2="DDI-PubMed.19801894.s16.e1" /></sentence><sentence text=" QUN (2 mg/kg, i"><entity charOffset="1-3" id="DDI-PubMed.19801894.s17.e0" text="QUN" /></sentence><sentence text=" v" /><sentence text=") was injected 2 hr after the last dose of KTZ or CIM"><entity charOffset="43-45" id="DDI-PubMed.19801894.s19.e0" text="KTZ" /><entity charOffset="50-52" id="DDI-PubMed.19801894.s19.e1" text="CIM" /><pair ddi="false" e1="DDI-PubMed.19801894.s19.e0" e2="DDI-PubMed.19801894.s19.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s19.e0" e2="DDI-PubMed.19801894.s19.e1" /></sentence><sentence text=" The analysis of the obtained pharmacokinetic parameters showed that, KTZ significantly reduced total body clearance of QUN by 35%, while CIM did not"><entity charOffset="70-72" id="DDI-PubMed.19801894.s20.e0" text="KTZ" /><entity charOffset="138-140" id="DDI-PubMed.19801894.s20.e1" text="CIM" /><entity charOffset="120-122" id="DDI-PubMed.19801894.s20.e2" text="QUN" /><pair ddi="false" e1="DDI-PubMed.19801894.s20.e0" e2="DDI-PubMed.19801894.s20.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s20.e0" e2="DDI-PubMed.19801894.s20.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s20.e0" e2="DDI-PubMed.19801894.s20.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s20.e2" e2="DDI-PubMed.19801894.s20.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s20.e2" e2="DDI-PubMed.19801894.s20.e1" /></sentence><sentence text=" These results suggest that, KTZ inhibits CYP3A activities (both in vitro and in vivo), but CIM does not"><entity charOffset="29-31" id="DDI-PubMed.19801894.s21.e0" text="KTZ" /><entity charOffset="92-94" id="DDI-PubMed.19801894.s21.e1" text="CIM" /><pair ddi="false" e1="DDI-PubMed.19801894.s21.e0" e2="DDI-PubMed.19801894.s21.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s21.e0" e2="DDI-PubMed.19801894.s21.e1" /></sentence><sentence text=" In clinical practice, therefore, KTZ may result in inhibition based drug-drug interaction with CYP3A substrates in cat patients, whereas CIM and ERY are unlikely to lead to interaction involving CYP3A substrates"><entity charOffset="34-36" id="DDI-PubMed.19801894.s22.e0" text="KTZ" /><entity charOffset="138-140" id="DDI-PubMed.19801894.s22.e1" text="CIM" /><entity charOffset="146-148" id="DDI-PubMed.19801894.s22.e2" text="ERY" /><pair ddi="false" e1="DDI-PubMed.19801894.s22.e0" e2="DDI-PubMed.19801894.s22.e0" /><pair ddi="false" e1="DDI-PubMed.19801894.s22.e0" e2="DDI-PubMed.19801894.s22.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s22.e0" e2="DDI-PubMed.19801894.s22.e2" /><pair ddi="false" e1="DDI-PubMed.19801894.s22.e1" e2="DDI-PubMed.19801894.s22.e1" /><pair ddi="false" e1="DDI-PubMed.19801894.s22.e1" e2="DDI-PubMed.19801894.s22.e2" /></sentence><sentence text="" /></document>